Related Experiment Video
Updated: Jul 7, 2026
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Global Vaccine Safety DataNet meeting
1Center for Global Child Health at Cincinnati Children's Hospital in Cincinnati, OH, USA. stevblack@gmail.com
Expert Review of Vaccines
|February 7, 2008
Summary
An international meeting discussed establishing a Global Vaccine Safety Data Network. Experts assessed capabilities and interest in creating a worldwide system for vaccine safety data collection and analysis.
Area of Science:
- Public Health
- Epidemiology
- Pharmacovigilance
Background:
- An international meeting convened experts from developed and developing nations, public health agencies, and pharmaceutical companies.
- The primary focus was to discuss the establishment of a Global Vaccine Safety Data Network.
- Participants aimed to address the growing need for robust vaccine safety surveillance.
Framework:
- The proposed network aims to connect existing and developing computerized vaccine safety databases.
- Key considerations include data standardization, interoperability, and secure data sharing protocols.
- The network will facilitate the collection of vaccine exposure and clinical outcome data.
Implementation:
- Discussions centered on assessing current data collection capabilities and user interest globally.
- Exploration of the necessary infrastructure, technological requirements, and sustainable funding models was conducted.
- The optimal approach for phased implementation and governance of the network was debated.
Implications:
- Establishing a Global Vaccine Safety Data Network can enhance post-marketing vaccine surveillance.
- Improved data sharing will enable more rapid detection of potential adverse events following immunization.
- This initiative supports global efforts to ensure vaccine safety and public trust in vaccination programs.
Related Concept Videos
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:51Vaccinations
Overview
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:28Survey Safety
Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...